Peter J. Millett, Center for Outcomes-Based Orthopaedic Research (COOR Steadman Philippon Research Institute, 181 West Meadow Drive, Suite 1000, Vail, CO 81657.
Am J Sports Med. 2013 Dec;41(12):2896-903. doi: 10.1177/0363546513502459. Epub 2013 Sep 5.
Reconstruction of the disrupted acromioclavicular (AC) joint has historically resulted in high complication rates. As a result, there has been a move toward anatomic coracoclavicular (CC) ligament fixation and reconstruction, owing to its numerous biomechanical advantages and perceived clinical advantages.
To report and analyze the unique complications associated with these anatomic CC ligament procedures using either cortical fixation buttons (CFBs) or tendon grafts (TGs) and to evaluate the effect that these complications have on patient outcomes.
Case series; Level of evidence, 4.
From January 2006 until May 2011, a total of 59 primary anatomic CC ligament procedures were performed using either CFBs or TGs. Demographic, surgical, subjective (including the American Shoulder and Elbow Surgeons [ASES], quick Disabilities of the Arm, Shoulder and Hand [QuickDASH], Short Form-12 [SF-12], and Single Assessment Numeric Evaluation [SANE] scores), and radiographic data along with surgical complications were prospectively collected and retrospectively analyzed. Construct survivorship, defined as the maintenance of reduction of the AC joint, was calculated using the Kaplan-Meier method at 12- and 24-month intervals.
Surgical treatment for AC joint dislocations was performed in 3 women (4 shoulders) and 52 men (55 shoulders) with a mean age of 43.6 years (range, 18-71 years); 13 shoulders (22.0%) underwent fixation using the CFB technique, and 46 shoulders (78.0%) underwent reconstruction using the TG technique. The overall complication rate was 27.1% (16/59) in this study. There were 3 complications (23.1%) in the CFB group, including 1 coracoid fracture and 2 cases of hardware failure resulting in a loss of reduction. There were 13 complications (28.2%) in the TG group, including 4 graft ruptures, 2 clavicle fractures, 1 case of hardware failure, 1 hypertrophic distal clavicle, 2 cases of hardware pain, 1 suture granuloma, 1 case of adhesive capsulitis, and 1 case of axillary neuropathy. Twelve- and 24-month construct survivorship was calculated to be 86.2% and 83.2%, respectively. Of the 43 shoulders that did not have a complication, mean ASES scores significantly improved from 57.5 (range, 0-97) to 91 (range, 63-100) (P < .001), and mean SF-12 physical component summary scores significantly improved from 45 (range, 25-58) to 56 (range, 43-65.8) (P < .001) after a mean 2.4-year follow-up (range, 1.0-5.7 years). There were no significant differences in outcomes between those that did and did not experience a complication, with the exception that those with complications had significantly decreased median patient satisfaction compared with those without complications (3.5 vs 9, respectively; P = .049).
Anatomic procedures to treat disrupted CC ligaments using either CFBs or TGs resulted in an overall complication rate of 27.1% (16/59). Construct survivorship was calculated to be 86.2% at 12 months and 83.2% at 24 months. Good to excellent outcomes could only be reported in those patients who did not have a complication.
重建中断的肩锁关节(AC)历来会导致高并发症发生率。因此,由于其众多的生物力学优势和临床优势,人们倾向于采用解剖型喙锁韧带(CC)固定和重建。
报告并分析使用皮质固定纽扣(CFB)或肌腱移植物(TG)进行这些解剖 CC 韧带手术的独特并发症,并评估这些并发症对患者结果的影响。
病例系列;证据水平,4 级。
从 2006 年 1 月至 2011 年 5 月,共对 59 例初次解剖 CC 韧带进行了手术,使用 CFB 或 TG。前瞻性收集并回顾性分析了人口统计学、手术、主观(包括美国肩肘外科医生协会 [ASES]、快速上肢残疾问卷 [QuickDASH]、简短表单-12 [SF-12] 和单一评估数值评估 [SANE] 评分)和放射学数据以及手术并发症。使用 Kaplan-Meier 方法在 12 个月和 24 个月的时间间隔内计算 AC 关节脱位的手术治疗中 CC 关节重建的结构存活率,定义为维持 AC 关节的复位。
本研究中,3 名女性(4 肩)和 52 名男性(55 肩)接受了 AC 关节脱位的手术治疗,平均年龄为 43.6 岁(范围,18-71 岁);13 肩(22.0%)采用 CFB 技术固定,46 肩(78.0%)采用 TG 技术重建。在这项研究中,总的并发症发生率为 27.1%(16/59)。CFB 组有 3 例(23.1%)并发症,包括 1 例喙突骨折和 2 例因复位丢失导致的内固定物失败。TG 组有 13 例(28.2%)并发症,包括 4 例移植物断裂、2 例锁骨骨折、1 例内固定物失败、1 例锁骨远端肥大、2 例内固定物疼痛、1 例缝线肉芽肿、1 例粘连性囊炎和 1 例腋神经病变。计算得出 12 个月和 24 个月的结构存活率分别为 86.2%和 83.2%。在没有并发症的 43 个肩中,平均 ASES 评分从 57.5(范围,0-97)显著改善至 91(范围,63-100)(P <.001),平均 SF-12 生理成分综合评分从 45(范围,25-58)显著改善至 56(范围,43-65.8)(P <.001)在平均 2.4 年的随访(范围,1.0-5.7 年)后。在是否发生并发症的患者中,结局没有显著差异,除了有并发症的患者的患者满意度中位数明显低于无并发症的患者(分别为 3.5 和 9,P =.049)。
使用 CFB 或 TG 治疗中断的 CC 韧带的解剖手术,总体并发症发生率为 27.1%(16/59)。12 个月时结构存活率计算为 86.2%,24 个月时为 83.2%。只有没有并发症的患者才能报告良好至优秀的结果。